Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/dont-tamper-with-patent-laws-a-srinivas-4678290/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/dont-tamper-with-patent-laws-a-srinivas-4678290/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/dont-tamper-with-patent-laws-a-srinivas-4678290/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/dont-tamper-with-patent-laws-a-srinivas-4678290/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f5d3462f729-trace').style.display = (document.getElementById('cakeErr67f5d3462f729-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f5d3462f729-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f5d3462f729-code').style.display = (document.getElementById('cakeErr67f5d3462f729-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f5d3462f729-context').style.display = (document.getElementById('cakeErr67f5d3462f729-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f5d3462f729-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f5d3462f729-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 30230,
		&#039;title&#039; =&gt; &#039;Don’t tamper with patent laws -A Srinivas&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu Business Line&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;India is being too accommodating of MNCs&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
The Centre is needlessly apologetic about our IPR laws. It set up an IPR &amp;lsquo;think tank&amp;rsquo; in October 2014, perhaps responding to a view that our IPRs are not strong enough to invite foreign investment. Last January, Prime Minister Modi and President Obama issued a joint statement which &amp;ldquo;committed to establish an annual high-level Intellectual Property Working Group&amp;rdquo;. In November, Modi said in Singapore that &amp;ldquo;India is committed to protect the intellectual property rights of all innovators&amp;rdquo;. And now, the Cabinet is expected to discuss a &amp;lsquo;new IPR policy&amp;rsquo; in a month.&lt;br /&gt;
&lt;br /&gt;
It appears that MNCs have lobbied with world governments after two setbacks in 2013. In April that year, the Supreme Court struck down a patent for Novartis&amp;rsquo; leukemia drug, Glivec, citing Section 3 (d) of the Patents Act which disallows superficial innovation. In March 2013, the Intellectual Property Appellate Board awarded Natco Pharma a compulsory licence to make and sell a cheaper version of Bayer&amp;rsquo;s anti-cancer drug, Nexavar. The MNCs&amp;rsquo; gripe against India&amp;rsquo;s patent law is unjustified. In the book, Politics Trumps Economics, Sunil Mani points out that the share of foreign companies in business enterprise R&amp;amp;D expenditure increased from 10 per cent in 2003 to 29 per cent in 2011. What&amp;rsquo;s more, &amp;ldquo;with tighter TRIPS-compliant IPR regime put in place by India, from 2005 onwards, the possibility of spill-overs to the domestic economy from the R&amp;amp;D done by these foreign companies stands greatly diminished&amp;rdquo;, he says. In other words, the MNCs are doing pretty well for themselves.&lt;br /&gt;
&lt;br /&gt;
Our patent law merely deploys the safeguards allowed in TRIPS to protect domestic consumers and industry. It is considered a model for the developing world. It enabled India to supply cheap anti-HIV drugs to South Africa. Why dismantle this system? India arguably conceded enough at the Nairobi ministerial. Our IPRs laws should be non-negotiable.
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindu Business Line, 8 January, 2016, http://www.thehindubusinessline.com/opinion/columns/dont-tamper-with-patent-laws/article8082555.ece?homepage=true&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;dont-tamper-with-patent-laws-a-srinivas-4678290&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4678290,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 30230,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Don’t tamper with patent laws -A Srinivas&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Intellectual Property Rights,IPRs,patent,Patented Medicines,patents,FDI,Foreign Direct Investment&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Hindu Business Line

India is being too accommodating of MNCs

The Centre is needlessly apologetic about our IPR laws. It set up an IPR &amp;lsquo;think tank&amp;rsquo; in October 2014, perhaps responding to a view that our IPRs are not strong enough...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu Business Line&lt;br /&gt;&lt;br /&gt;&lt;em&gt;India is being too accommodating of MNCs&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;The Centre is needlessly apologetic about our IPR laws. It set up an IPR &amp;lsquo;think tank&amp;rsquo; in October 2014, perhaps responding to a view that our IPRs are not strong enough to invite foreign investment. Last January, Prime Minister Modi and President Obama issued a joint statement which &amp;ldquo;committed to establish an annual high-level Intellectual Property Working Group&amp;rdquo;. In November, Modi said in Singapore that &amp;ldquo;India is committed to protect the intellectual property rights of all innovators&amp;rdquo;. And now, the Cabinet is expected to discuss a &amp;lsquo;new IPR policy&amp;rsquo; in a month.&lt;br /&gt;&lt;br /&gt;It appears that MNCs have lobbied with world governments after two setbacks in 2013. In April that year, the Supreme Court struck down a patent for Novartis&amp;rsquo; leukemia drug, Glivec, citing Section 3 (d) of the Patents Act which disallows superficial innovation. In March 2013, the Intellectual Property Appellate Board awarded Natco Pharma a compulsory licence to make and sell a cheaper version of Bayer&amp;rsquo;s anti-cancer drug, Nexavar. The MNCs&amp;rsquo; gripe against India&amp;rsquo;s patent law is unjustified. In the book, Politics Trumps Economics, Sunil Mani points out that the share of foreign companies in business enterprise R&amp;amp;D expenditure increased from 10 per cent in 2003 to 29 per cent in 2011. What&amp;rsquo;s more, &amp;ldquo;with tighter TRIPS-compliant IPR regime put in place by India, from 2005 onwards, the possibility of spill-overs to the domestic economy from the R&amp;amp;D done by these foreign companies stands greatly diminished&amp;rdquo;, he says. In other words, the MNCs are doing pretty well for themselves.&lt;br /&gt;&lt;br /&gt;Our patent law merely deploys the safeguards allowed in TRIPS to protect domestic consumers and industry. It is considered a model for the developing world. It enabled India to supply cheap anti-HIV drugs to South Africa. Why dismantle this system? India arguably conceded enough at the Nairobi ministerial. Our IPRs laws should be non-negotiable.&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 30230,
	&#039;title&#039; =&gt; &#039;Don’t tamper with patent laws -A Srinivas&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu Business Line&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;India is being too accommodating of MNCs&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
The Centre is needlessly apologetic about our IPR laws. It set up an IPR &amp;lsquo;think tank&amp;rsquo; in October 2014, perhaps responding to a view that our IPRs are not strong enough to invite foreign investment. Last January, Prime Minister Modi and President Obama issued a joint statement which &amp;ldquo;committed to establish an annual high-level Intellectual Property Working Group&amp;rdquo;. In November, Modi said in Singapore that &amp;ldquo;India is committed to protect the intellectual property rights of all innovators&amp;rdquo;. And now, the Cabinet is expected to discuss a &amp;lsquo;new IPR policy&amp;rsquo; in a month.&lt;br /&gt;
&lt;br /&gt;
It appears that MNCs have lobbied with world governments after two setbacks in 2013. In April that year, the Supreme Court struck down a patent for Novartis&amp;rsquo; leukemia drug, Glivec, citing Section 3 (d) of the Patents Act which disallows superficial innovation. In March 2013, the Intellectual Property Appellate Board awarded Natco Pharma a compulsory licence to make and sell a cheaper version of Bayer&amp;rsquo;s anti-cancer drug, Nexavar. The MNCs&amp;rsquo; gripe against India&amp;rsquo;s patent law is unjustified. In the book, Politics Trumps Economics, Sunil Mani points out that the share of foreign companies in business enterprise R&amp;amp;D expenditure increased from 10 per cent in 2003 to 29 per cent in 2011. What&amp;rsquo;s more, &amp;ldquo;with tighter TRIPS-compliant IPR regime put in place by India, from 2005 onwards, the possibility of spill-overs to the domestic economy from the R&amp;amp;D done by these foreign companies stands greatly diminished&amp;rdquo;, he says. In other words, the MNCs are doing pretty well for themselves.&lt;br /&gt;
&lt;br /&gt;
Our patent law merely deploys the safeguards allowed in TRIPS to protect domestic consumers and industry. It is considered a model for the developing world. It enabled India to supply cheap anti-HIV drugs to South Africa. Why dismantle this system? India arguably conceded enough at the Nairobi ministerial. Our IPRs laws should be non-negotiable.
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindu Business Line, 8 January, 2016, http://www.thehindubusinessline.com/opinion/columns/dont-tamper-with-patent-laws/article8082555.ece?homepage=true&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;dont-tamper-with-patent-laws-a-srinivas-4678290&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4678290,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 30230
$metaTitle = &#039;LATEST NEWS UPDATES | Don’t tamper with patent laws -A Srinivas&#039;
$metaKeywords = &#039;Intellectual Property Rights,IPRs,patent,Patented Medicines,patents,FDI,Foreign Direct Investment&#039;
$metaDesc = &#039;
-The Hindu Business Line

India is being too accommodating of MNCs

The Centre is needlessly apologetic about our IPR laws. It set up an IPR &amp;lsquo;think tank&amp;rsquo; in October 2014, perhaps responding to a view that our IPRs are not strong enough...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu Business Line&lt;br /&gt;&lt;br /&gt;&lt;em&gt;India is being too accommodating of MNCs&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;The Centre is needlessly apologetic about our IPR laws. It set up an IPR &amp;lsquo;think tank&amp;rsquo; in October 2014, perhaps responding to a view that our IPRs are not strong enough to invite foreign investment. Last January, Prime Minister Modi and President Obama issued a joint statement which &amp;ldquo;committed to establish an annual high-level Intellectual Property Working Group&amp;rdquo;. In November, Modi said in Singapore that &amp;ldquo;India is committed to protect the intellectual property rights of all innovators&amp;rdquo;. And now, the Cabinet is expected to discuss a &amp;lsquo;new IPR policy&amp;rsquo; in a month.&lt;br /&gt;&lt;br /&gt;It appears that MNCs have lobbied with world governments after two setbacks in 2013. In April that year, the Supreme Court struck down a patent for Novartis&amp;rsquo; leukemia drug, Glivec, citing Section 3 (d) of the Patents Act which disallows superficial innovation. In March 2013, the Intellectual Property Appellate Board awarded Natco Pharma a compulsory licence to make and sell a cheaper version of Bayer&amp;rsquo;s anti-cancer drug, Nexavar. The MNCs&amp;rsquo; gripe against India&amp;rsquo;s patent law is unjustified. In the book, Politics Trumps Economics, Sunil Mani points out that the share of foreign companies in business enterprise R&amp;amp;D expenditure increased from 10 per cent in 2003 to 29 per cent in 2011. What&amp;rsquo;s more, &amp;ldquo;with tighter TRIPS-compliant IPR regime put in place by India, from 2005 onwards, the possibility of spill-overs to the domestic economy from the R&amp;amp;D done by these foreign companies stands greatly diminished&amp;rdquo;, he says. In other words, the MNCs are doing pretty well for themselves.&lt;br /&gt;&lt;br /&gt;Our patent law merely deploys the safeguards allowed in TRIPS to protect domestic consumers and industry. It is considered a model for the developing world. It enabled India to supply cheap anti-HIV drugs to South Africa. Why dismantle this system? India arguably conceded enough at the Nairobi ministerial. Our IPRs laws should be non-negotiable.&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/dont-tamper-with-patent-laws-a-srinivas-4678290.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Don’t tamper with patent laws -A Srinivas | Im4change.org</title>
    <meta name="description" content="
-The Hindu Business Line

India is being too accommodating of MNCs

The Centre is needlessly apologetic about our IPR laws. It set up an IPR &lsquo;think tank&rsquo; in October 2014, perhaps responding to a view that our IPRs are not strong enough..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Don’t tamper with patent laws -A Srinivas</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Hindu Business Line<br /><br /><em>India is being too accommodating of MNCs<br /></em><br />The Centre is needlessly apologetic about our IPR laws. It set up an IPR &lsquo;think tank&rsquo; in October 2014, perhaps responding to a view that our IPRs are not strong enough to invite foreign investment. Last January, Prime Minister Modi and President Obama issued a joint statement which &ldquo;committed to establish an annual high-level Intellectual Property Working Group&rdquo;. In November, Modi said in Singapore that &ldquo;India is committed to protect the intellectual property rights of all innovators&rdquo;. And now, the Cabinet is expected to discuss a &lsquo;new IPR policy&rsquo; in a month.<br /><br />It appears that MNCs have lobbied with world governments after two setbacks in 2013. In April that year, the Supreme Court struck down a patent for Novartis&rsquo; leukemia drug, Glivec, citing Section 3 (d) of the Patents Act which disallows superficial innovation. In March 2013, the Intellectual Property Appellate Board awarded Natco Pharma a compulsory licence to make and sell a cheaper version of Bayer&rsquo;s anti-cancer drug, Nexavar. The MNCs&rsquo; gripe against India&rsquo;s patent law is unjustified. In the book, Politics Trumps Economics, Sunil Mani points out that the share of foreign companies in business enterprise R&amp;D expenditure increased from 10 per cent in 2003 to 29 per cent in 2011. What&rsquo;s more, &ldquo;with tighter TRIPS-compliant IPR regime put in place by India, from 2005 onwards, the possibility of spill-overs to the domestic economy from the R&amp;D done by these foreign companies stands greatly diminished&rdquo;, he says. In other words, the MNCs are doing pretty well for themselves.<br /><br />Our patent law merely deploys the safeguards allowed in TRIPS to protect domestic consumers and industry. It is considered a model for the developing world. It enabled India to supply cheap anti-HIV drugs to South Africa. Why dismantle this system? India arguably conceded enough at the Nairobi ministerial. Our IPRs laws should be non-negotiable.</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f5d3462f729-trace').style.display = (document.getElementById('cakeErr67f5d3462f729-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f5d3462f729-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f5d3462f729-code').style.display = (document.getElementById('cakeErr67f5d3462f729-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f5d3462f729-context').style.display = (document.getElementById('cakeErr67f5d3462f729-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f5d3462f729-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f5d3462f729-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 30230,
		&#039;title&#039; =&gt; &#039;Don’t tamper with patent laws -A Srinivas&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu Business Line&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;India is being too accommodating of MNCs&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
The Centre is needlessly apologetic about our IPR laws. It set up an IPR &amp;lsquo;think tank&amp;rsquo; in October 2014, perhaps responding to a view that our IPRs are not strong enough to invite foreign investment. Last January, Prime Minister Modi and President Obama issued a joint statement which &amp;ldquo;committed to establish an annual high-level Intellectual Property Working Group&amp;rdquo;. In November, Modi said in Singapore that &amp;ldquo;India is committed to protect the intellectual property rights of all innovators&amp;rdquo;. And now, the Cabinet is expected to discuss a &amp;lsquo;new IPR policy&amp;rsquo; in a month.&lt;br /&gt;
&lt;br /&gt;
It appears that MNCs have lobbied with world governments after two setbacks in 2013. In April that year, the Supreme Court struck down a patent for Novartis&amp;rsquo; leukemia drug, Glivec, citing Section 3 (d) of the Patents Act which disallows superficial innovation. In March 2013, the Intellectual Property Appellate Board awarded Natco Pharma a compulsory licence to make and sell a cheaper version of Bayer&amp;rsquo;s anti-cancer drug, Nexavar. The MNCs&amp;rsquo; gripe against India&amp;rsquo;s patent law is unjustified. In the book, Politics Trumps Economics, Sunil Mani points out that the share of foreign companies in business enterprise R&amp;amp;D expenditure increased from 10 per cent in 2003 to 29 per cent in 2011. What&amp;rsquo;s more, &amp;ldquo;with tighter TRIPS-compliant IPR regime put in place by India, from 2005 onwards, the possibility of spill-overs to the domestic economy from the R&amp;amp;D done by these foreign companies stands greatly diminished&amp;rdquo;, he says. In other words, the MNCs are doing pretty well for themselves.&lt;br /&gt;
&lt;br /&gt;
Our patent law merely deploys the safeguards allowed in TRIPS to protect domestic consumers and industry. It is considered a model for the developing world. It enabled India to supply cheap anti-HIV drugs to South Africa. Why dismantle this system? India arguably conceded enough at the Nairobi ministerial. Our IPRs laws should be non-negotiable.
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindu Business Line, 8 January, 2016, http://www.thehindubusinessline.com/opinion/columns/dont-tamper-with-patent-laws/article8082555.ece?homepage=true&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;dont-tamper-with-patent-laws-a-srinivas-4678290&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4678290,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 30230,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Don’t tamper with patent laws -A Srinivas&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Intellectual Property Rights,IPRs,patent,Patented Medicines,patents,FDI,Foreign Direct Investment&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Hindu Business Line

India is being too accommodating of MNCs

The Centre is needlessly apologetic about our IPR laws. It set up an IPR &amp;lsquo;think tank&amp;rsquo; in October 2014, perhaps responding to a view that our IPRs are not strong enough...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu Business Line&lt;br /&gt;&lt;br /&gt;&lt;em&gt;India is being too accommodating of MNCs&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;The Centre is needlessly apologetic about our IPR laws. It set up an IPR &amp;lsquo;think tank&amp;rsquo; in October 2014, perhaps responding to a view that our IPRs are not strong enough to invite foreign investment. Last January, Prime Minister Modi and President Obama issued a joint statement which &amp;ldquo;committed to establish an annual high-level Intellectual Property Working Group&amp;rdquo;. In November, Modi said in Singapore that &amp;ldquo;India is committed to protect the intellectual property rights of all innovators&amp;rdquo;. And now, the Cabinet is expected to discuss a &amp;lsquo;new IPR policy&amp;rsquo; in a month.&lt;br /&gt;&lt;br /&gt;It appears that MNCs have lobbied with world governments after two setbacks in 2013. In April that year, the Supreme Court struck down a patent for Novartis&amp;rsquo; leukemia drug, Glivec, citing Section 3 (d) of the Patents Act which disallows superficial innovation. In March 2013, the Intellectual Property Appellate Board awarded Natco Pharma a compulsory licence to make and sell a cheaper version of Bayer&amp;rsquo;s anti-cancer drug, Nexavar. The MNCs&amp;rsquo; gripe against India&amp;rsquo;s patent law is unjustified. In the book, Politics Trumps Economics, Sunil Mani points out that the share of foreign companies in business enterprise R&amp;amp;D expenditure increased from 10 per cent in 2003 to 29 per cent in 2011. What&amp;rsquo;s more, &amp;ldquo;with tighter TRIPS-compliant IPR regime put in place by India, from 2005 onwards, the possibility of spill-overs to the domestic economy from the R&amp;amp;D done by these foreign companies stands greatly diminished&amp;rdquo;, he says. In other words, the MNCs are doing pretty well for themselves.&lt;br /&gt;&lt;br /&gt;Our patent law merely deploys the safeguards allowed in TRIPS to protect domestic consumers and industry. It is considered a model for the developing world. It enabled India to supply cheap anti-HIV drugs to South Africa. Why dismantle this system? India arguably conceded enough at the Nairobi ministerial. Our IPRs laws should be non-negotiable.&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 30230,
	&#039;title&#039; =&gt; &#039;Don’t tamper with patent laws -A Srinivas&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu Business Line&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;India is being too accommodating of MNCs&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
The Centre is needlessly apologetic about our IPR laws. It set up an IPR &amp;lsquo;think tank&amp;rsquo; in October 2014, perhaps responding to a view that our IPRs are not strong enough to invite foreign investment. Last January, Prime Minister Modi and President Obama issued a joint statement which &amp;ldquo;committed to establish an annual high-level Intellectual Property Working Group&amp;rdquo;. In November, Modi said in Singapore that &amp;ldquo;India is committed to protect the intellectual property rights of all innovators&amp;rdquo;. And now, the Cabinet is expected to discuss a &amp;lsquo;new IPR policy&amp;rsquo; in a month.&lt;br /&gt;
&lt;br /&gt;
It appears that MNCs have lobbied with world governments after two setbacks in 2013. In April that year, the Supreme Court struck down a patent for Novartis&amp;rsquo; leukemia drug, Glivec, citing Section 3 (d) of the Patents Act which disallows superficial innovation. In March 2013, the Intellectual Property Appellate Board awarded Natco Pharma a compulsory licence to make and sell a cheaper version of Bayer&amp;rsquo;s anti-cancer drug, Nexavar. The MNCs&amp;rsquo; gripe against India&amp;rsquo;s patent law is unjustified. In the book, Politics Trumps Economics, Sunil Mani points out that the share of foreign companies in business enterprise R&amp;amp;D expenditure increased from 10 per cent in 2003 to 29 per cent in 2011. What&amp;rsquo;s more, &amp;ldquo;with tighter TRIPS-compliant IPR regime put in place by India, from 2005 onwards, the possibility of spill-overs to the domestic economy from the R&amp;amp;D done by these foreign companies stands greatly diminished&amp;rdquo;, he says. In other words, the MNCs are doing pretty well for themselves.&lt;br /&gt;
&lt;br /&gt;
Our patent law merely deploys the safeguards allowed in TRIPS to protect domestic consumers and industry. It is considered a model for the developing world. It enabled India to supply cheap anti-HIV drugs to South Africa. Why dismantle this system? India arguably conceded enough at the Nairobi ministerial. Our IPRs laws should be non-negotiable.
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindu Business Line, 8 January, 2016, http://www.thehindubusinessline.com/opinion/columns/dont-tamper-with-patent-laws/article8082555.ece?homepage=true&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;dont-tamper-with-patent-laws-a-srinivas-4678290&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4678290,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 30230
$metaTitle = &#039;LATEST NEWS UPDATES | Don’t tamper with patent laws -A Srinivas&#039;
$metaKeywords = &#039;Intellectual Property Rights,IPRs,patent,Patented Medicines,patents,FDI,Foreign Direct Investment&#039;
$metaDesc = &#039;
-The Hindu Business Line

India is being too accommodating of MNCs

The Centre is needlessly apologetic about our IPR laws. It set up an IPR &amp;lsquo;think tank&amp;rsquo; in October 2014, perhaps responding to a view that our IPRs are not strong enough...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu Business Line&lt;br /&gt;&lt;br /&gt;&lt;em&gt;India is being too accommodating of MNCs&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;The Centre is needlessly apologetic about our IPR laws. It set up an IPR &amp;lsquo;think tank&amp;rsquo; in October 2014, perhaps responding to a view that our IPRs are not strong enough to invite foreign investment. Last January, Prime Minister Modi and President Obama issued a joint statement which &amp;ldquo;committed to establish an annual high-level Intellectual Property Working Group&amp;rdquo;. In November, Modi said in Singapore that &amp;ldquo;India is committed to protect the intellectual property rights of all innovators&amp;rdquo;. And now, the Cabinet is expected to discuss a &amp;lsquo;new IPR policy&amp;rsquo; in a month.&lt;br /&gt;&lt;br /&gt;It appears that MNCs have lobbied with world governments after two setbacks in 2013. In April that year, the Supreme Court struck down a patent for Novartis&amp;rsquo; leukemia drug, Glivec, citing Section 3 (d) of the Patents Act which disallows superficial innovation. In March 2013, the Intellectual Property Appellate Board awarded Natco Pharma a compulsory licence to make and sell a cheaper version of Bayer&amp;rsquo;s anti-cancer drug, Nexavar. The MNCs&amp;rsquo; gripe against India&amp;rsquo;s patent law is unjustified. In the book, Politics Trumps Economics, Sunil Mani points out that the share of foreign companies in business enterprise R&amp;amp;D expenditure increased from 10 per cent in 2003 to 29 per cent in 2011. What&amp;rsquo;s more, &amp;ldquo;with tighter TRIPS-compliant IPR regime put in place by India, from 2005 onwards, the possibility of spill-overs to the domestic economy from the R&amp;amp;D done by these foreign companies stands greatly diminished&amp;rdquo;, he says. In other words, the MNCs are doing pretty well for themselves.&lt;br /&gt;&lt;br /&gt;Our patent law merely deploys the safeguards allowed in TRIPS to protect domestic consumers and industry. It is considered a model for the developing world. It enabled India to supply cheap anti-HIV drugs to South Africa. Why dismantle this system? India arguably conceded enough at the Nairobi ministerial. Our IPRs laws should be non-negotiable.&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/dont-tamper-with-patent-laws-a-srinivas-4678290.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Don’t tamper with patent laws -A Srinivas | Im4change.org</title>
    <meta name="description" content="
-The Hindu Business Line

India is being too accommodating of MNCs

The Centre is needlessly apologetic about our IPR laws. It set up an IPR &lsquo;think tank&rsquo; in October 2014, perhaps responding to a view that our IPRs are not strong enough..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Don’t tamper with patent laws -A Srinivas</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Hindu Business Line<br /><br /><em>India is being too accommodating of MNCs<br /></em><br />The Centre is needlessly apologetic about our IPR laws. It set up an IPR &lsquo;think tank&rsquo; in October 2014, perhaps responding to a view that our IPRs are not strong enough to invite foreign investment. Last January, Prime Minister Modi and President Obama issued a joint statement which &ldquo;committed to establish an annual high-level Intellectual Property Working Group&rdquo;. In November, Modi said in Singapore that &ldquo;India is committed to protect the intellectual property rights of all innovators&rdquo;. And now, the Cabinet is expected to discuss a &lsquo;new IPR policy&rsquo; in a month.<br /><br />It appears that MNCs have lobbied with world governments after two setbacks in 2013. In April that year, the Supreme Court struck down a patent for Novartis&rsquo; leukemia drug, Glivec, citing Section 3 (d) of the Patents Act which disallows superficial innovation. In March 2013, the Intellectual Property Appellate Board awarded Natco Pharma a compulsory licence to make and sell a cheaper version of Bayer&rsquo;s anti-cancer drug, Nexavar. The MNCs&rsquo; gripe against India&rsquo;s patent law is unjustified. In the book, Politics Trumps Economics, Sunil Mani points out that the share of foreign companies in business enterprise R&amp;D expenditure increased from 10 per cent in 2003 to 29 per cent in 2011. What&rsquo;s more, &ldquo;with tighter TRIPS-compliant IPR regime put in place by India, from 2005 onwards, the possibility of spill-overs to the domestic economy from the R&amp;D done by these foreign companies stands greatly diminished&rdquo;, he says. In other words, the MNCs are doing pretty well for themselves.<br /><br />Our patent law merely deploys the safeguards allowed in TRIPS to protect domestic consumers and industry. It is considered a model for the developing world. It enabled India to supply cheap anti-HIV drugs to South Africa. Why dismantle this system? India arguably conceded enough at the Nairobi ministerial. Our IPRs laws should be non-negotiable.</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f5d3462f729-trace').style.display = (document.getElementById('cakeErr67f5d3462f729-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f5d3462f729-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f5d3462f729-code').style.display = (document.getElementById('cakeErr67f5d3462f729-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f5d3462f729-context').style.display = (document.getElementById('cakeErr67f5d3462f729-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f5d3462f729-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f5d3462f729-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 30230,
		&#039;title&#039; =&gt; &#039;Don’t tamper with patent laws -A Srinivas&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu Business Line&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;India is being too accommodating of MNCs&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
The Centre is needlessly apologetic about our IPR laws. It set up an IPR &amp;lsquo;think tank&amp;rsquo; in October 2014, perhaps responding to a view that our IPRs are not strong enough to invite foreign investment. Last January, Prime Minister Modi and President Obama issued a joint statement which &amp;ldquo;committed to establish an annual high-level Intellectual Property Working Group&amp;rdquo;. In November, Modi said in Singapore that &amp;ldquo;India is committed to protect the intellectual property rights of all innovators&amp;rdquo;. And now, the Cabinet is expected to discuss a &amp;lsquo;new IPR policy&amp;rsquo; in a month.&lt;br /&gt;
&lt;br /&gt;
It appears that MNCs have lobbied with world governments after two setbacks in 2013. In April that year, the Supreme Court struck down a patent for Novartis&amp;rsquo; leukemia drug, Glivec, citing Section 3 (d) of the Patents Act which disallows superficial innovation. In March 2013, the Intellectual Property Appellate Board awarded Natco Pharma a compulsory licence to make and sell a cheaper version of Bayer&amp;rsquo;s anti-cancer drug, Nexavar. The MNCs&amp;rsquo; gripe against India&amp;rsquo;s patent law is unjustified. In the book, Politics Trumps Economics, Sunil Mani points out that the share of foreign companies in business enterprise R&amp;amp;D expenditure increased from 10 per cent in 2003 to 29 per cent in 2011. What&amp;rsquo;s more, &amp;ldquo;with tighter TRIPS-compliant IPR regime put in place by India, from 2005 onwards, the possibility of spill-overs to the domestic economy from the R&amp;amp;D done by these foreign companies stands greatly diminished&amp;rdquo;, he says. In other words, the MNCs are doing pretty well for themselves.&lt;br /&gt;
&lt;br /&gt;
Our patent law merely deploys the safeguards allowed in TRIPS to protect domestic consumers and industry. It is considered a model for the developing world. It enabled India to supply cheap anti-HIV drugs to South Africa. Why dismantle this system? India arguably conceded enough at the Nairobi ministerial. Our IPRs laws should be non-negotiable.
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Hindu Business Line, 8 January, 2016, http://www.thehindubusinessline.com/opinion/columns/dont-tamper-with-patent-laws/article8082555.ece?homepage=true&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;dont-tamper-with-patent-laws-a-srinivas-4678290&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4678290,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 30230,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | Don’t tamper with patent laws -A Srinivas&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;Intellectual Property Rights,IPRs,patent,Patented Medicines,patents,FDI,Foreign Direct Investment&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Hindu Business Line

India is being too accommodating of MNCs

The Centre is needlessly apologetic about our IPR laws. It set up an IPR &amp;lsquo;think tank&amp;rsquo; in October 2014, perhaps responding to a view that our IPRs are not strong enough...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu Business Line&lt;br /&gt;&lt;br /&gt;&lt;em&gt;India is being too accommodating of MNCs&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;The Centre is needlessly apologetic about our IPR laws. It set up an IPR &amp;lsquo;think tank&amp;rsquo; in October 2014, perhaps responding to a view that our IPRs are not strong enough to invite foreign investment. Last January, Prime Minister Modi and President Obama issued a joint statement which &amp;ldquo;committed to establish an annual high-level Intellectual Property Working Group&amp;rdquo;. In November, Modi said in Singapore that &amp;ldquo;India is committed to protect the intellectual property rights of all innovators&amp;rdquo;. And now, the Cabinet is expected to discuss a &amp;lsquo;new IPR policy&amp;rsquo; in a month.&lt;br /&gt;&lt;br /&gt;It appears that MNCs have lobbied with world governments after two setbacks in 2013. In April that year, the Supreme Court struck down a patent for Novartis&amp;rsquo; leukemia drug, Glivec, citing Section 3 (d) of the Patents Act which disallows superficial innovation. In March 2013, the Intellectual Property Appellate Board awarded Natco Pharma a compulsory licence to make and sell a cheaper version of Bayer&amp;rsquo;s anti-cancer drug, Nexavar. The MNCs&amp;rsquo; gripe against India&amp;rsquo;s patent law is unjustified. In the book, Politics Trumps Economics, Sunil Mani points out that the share of foreign companies in business enterprise R&amp;amp;D expenditure increased from 10 per cent in 2003 to 29 per cent in 2011. What&amp;rsquo;s more, &amp;ldquo;with tighter TRIPS-compliant IPR regime put in place by India, from 2005 onwards, the possibility of spill-overs to the domestic economy from the R&amp;amp;D done by these foreign companies stands greatly diminished&amp;rdquo;, he says. In other words, the MNCs are doing pretty well for themselves.&lt;br /&gt;&lt;br /&gt;Our patent law merely deploys the safeguards allowed in TRIPS to protect domestic consumers and industry. It is considered a model for the developing world. It enabled India to supply cheap anti-HIV drugs to South Africa. Why dismantle this system? India arguably conceded enough at the Nairobi ministerial. Our IPRs laws should be non-negotiable.&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 30230,
	&#039;title&#039; =&gt; &#039;Don’t tamper with patent laws -A Srinivas&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Hindu Business Line&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;India is being too accommodating of MNCs&lt;br /&gt;
&lt;/em&gt;&lt;br /&gt;
The Centre is needlessly apologetic about our IPR laws. It set up an IPR &amp;lsquo;think tank&amp;rsquo; in October 2014, perhaps responding to a view that our IPRs are not strong enough to invite foreign investment. Last January, Prime Minister Modi and President Obama issued a joint statement which &amp;ldquo;committed to establish an annual high-level Intellectual Property Working Group&amp;rdquo;. In November, Modi said in Singapore that &amp;ldquo;India is committed to protect the intellectual property rights of all innovators&amp;rdquo;. And now, the Cabinet is expected to discuss a &amp;lsquo;new IPR policy&amp;rsquo; in a month.&lt;br /&gt;
&lt;br /&gt;
It appears that MNCs have lobbied with world governments after two setbacks in 2013. In April that year, the Supreme Court struck down a patent for Novartis&amp;rsquo; leukemia drug, Glivec, citing Section 3 (d) of the Patents Act which disallows superficial innovation. In March 2013, the Intellectual Property Appellate Board awarded Natco Pharma a compulsory licence to make and sell a cheaper version of Bayer&amp;rsquo;s anti-cancer drug, Nexavar. The MNCs&amp;rsquo; gripe against India&amp;rsquo;s patent law is unjustified. In the book, Politics Trumps Economics, Sunil Mani points out that the share of foreign companies in business enterprise R&amp;amp;D expenditure increased from 10 per cent in 2003 to 29 per cent in 2011. What&amp;rsquo;s more, &amp;ldquo;with tighter TRIPS-compliant IPR regime put in place by India, from 2005 onwards, the possibility of spill-overs to the domestic economy from the R&amp;amp;D done by these foreign companies stands greatly diminished&amp;rdquo;, he says. In other words, the MNCs are doing pretty well for themselves.&lt;br /&gt;
&lt;br /&gt;
Our patent law merely deploys the safeguards allowed in TRIPS to protect domestic consumers and industry. It is considered a model for the developing world. It enabled India to supply cheap anti-HIV drugs to South Africa. Why dismantle this system? India arguably conceded enough at the Nairobi ministerial. Our IPRs laws should be non-negotiable.
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Hindu Business Line, 8 January, 2016, http://www.thehindubusinessline.com/opinion/columns/dont-tamper-with-patent-laws/article8082555.ece?homepage=true&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;dont-tamper-with-patent-laws-a-srinivas-4678290&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4678290,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {},
		(int) 5 =&gt; object(Cake\ORM\Entity) {},
		(int) 6 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 30230
$metaTitle = &#039;LATEST NEWS UPDATES | Don’t tamper with patent laws -A Srinivas&#039;
$metaKeywords = &#039;Intellectual Property Rights,IPRs,patent,Patented Medicines,patents,FDI,Foreign Direct Investment&#039;
$metaDesc = &#039;
-The Hindu Business Line

India is being too accommodating of MNCs

The Centre is needlessly apologetic about our IPR laws. It set up an IPR &amp;lsquo;think tank&amp;rsquo; in October 2014, perhaps responding to a view that our IPRs are not strong enough...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Hindu Business Line&lt;br /&gt;&lt;br /&gt;&lt;em&gt;India is being too accommodating of MNCs&lt;br /&gt;&lt;/em&gt;&lt;br /&gt;The Centre is needlessly apologetic about our IPR laws. It set up an IPR &amp;lsquo;think tank&amp;rsquo; in October 2014, perhaps responding to a view that our IPRs are not strong enough to invite foreign investment. Last January, Prime Minister Modi and President Obama issued a joint statement which &amp;ldquo;committed to establish an annual high-level Intellectual Property Working Group&amp;rdquo;. In November, Modi said in Singapore that &amp;ldquo;India is committed to protect the intellectual property rights of all innovators&amp;rdquo;. And now, the Cabinet is expected to discuss a &amp;lsquo;new IPR policy&amp;rsquo; in a month.&lt;br /&gt;&lt;br /&gt;It appears that MNCs have lobbied with world governments after two setbacks in 2013. In April that year, the Supreme Court struck down a patent for Novartis&amp;rsquo; leukemia drug, Glivec, citing Section 3 (d) of the Patents Act which disallows superficial innovation. In March 2013, the Intellectual Property Appellate Board awarded Natco Pharma a compulsory licence to make and sell a cheaper version of Bayer&amp;rsquo;s anti-cancer drug, Nexavar. The MNCs&amp;rsquo; gripe against India&amp;rsquo;s patent law is unjustified. In the book, Politics Trumps Economics, Sunil Mani points out that the share of foreign companies in business enterprise R&amp;amp;D expenditure increased from 10 per cent in 2003 to 29 per cent in 2011. What&amp;rsquo;s more, &amp;ldquo;with tighter TRIPS-compliant IPR regime put in place by India, from 2005 onwards, the possibility of spill-overs to the domestic economy from the R&amp;amp;D done by these foreign companies stands greatly diminished&amp;rdquo;, he says. In other words, the MNCs are doing pretty well for themselves.&lt;br /&gt;&lt;br /&gt;Our patent law merely deploys the safeguards allowed in TRIPS to protect domestic consumers and industry. It is considered a model for the developing world. It enabled India to supply cheap anti-HIV drugs to South Africa. Why dismantle this system? India arguably conceded enough at the Nairobi ministerial. Our IPRs laws should be non-negotiable.&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/dont-tamper-with-patent-laws-a-srinivas-4678290.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | Don’t tamper with patent laws -A Srinivas | Im4change.org</title>
    <meta name="description" content="
-The Hindu Business Line

India is being too accommodating of MNCs

The Centre is needlessly apologetic about our IPR laws. It set up an IPR &lsquo;think tank&rsquo; in October 2014, perhaps responding to a view that our IPRs are not strong enough..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>Don’t tamper with patent laws -A Srinivas</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Hindu Business Line<br /><br /><em>India is being too accommodating of MNCs<br /></em><br />The Centre is needlessly apologetic about our IPR laws. It set up an IPR &lsquo;think tank&rsquo; in October 2014, perhaps responding to a view that our IPRs are not strong enough to invite foreign investment. Last January, Prime Minister Modi and President Obama issued a joint statement which &ldquo;committed to establish an annual high-level Intellectual Property Working Group&rdquo;. In November, Modi said in Singapore that &ldquo;India is committed to protect the intellectual property rights of all innovators&rdquo;. And now, the Cabinet is expected to discuss a &lsquo;new IPR policy&rsquo; in a month.<br /><br />It appears that MNCs have lobbied with world governments after two setbacks in 2013. In April that year, the Supreme Court struck down a patent for Novartis&rsquo; leukemia drug, Glivec, citing Section 3 (d) of the Patents Act which disallows superficial innovation. In March 2013, the Intellectual Property Appellate Board awarded Natco Pharma a compulsory licence to make and sell a cheaper version of Bayer&rsquo;s anti-cancer drug, Nexavar. The MNCs&rsquo; gripe against India&rsquo;s patent law is unjustified. In the book, Politics Trumps Economics, Sunil Mani points out that the share of foreign companies in business enterprise R&amp;D expenditure increased from 10 per cent in 2003 to 29 per cent in 2011. What&rsquo;s more, &ldquo;with tighter TRIPS-compliant IPR regime put in place by India, from 2005 onwards, the possibility of spill-overs to the domestic economy from the R&amp;D done by these foreign companies stands greatly diminished&rdquo;, he says. In other words, the MNCs are doing pretty well for themselves.<br /><br />Our patent law merely deploys the safeguards allowed in TRIPS to protect domestic consumers and industry. It is considered a model for the developing world. It enabled India to supply cheap anti-HIV drugs to South Africa. Why dismantle this system? India arguably conceded enough at the Nairobi ministerial. Our IPRs laws should be non-negotiable.</div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 30230,
		'title' => 'Don’t tamper with patent laws -A Srinivas',
		'subheading' => '',
		'description' => '<div align="justify">
-The Hindu Business Line<br />
<br />
<em>India is being too accommodating of MNCs<br />
</em><br />
The Centre is needlessly apologetic about our IPR laws. It set up an IPR &lsquo;think tank&rsquo; in October 2014, perhaps responding to a view that our IPRs are not strong enough to invite foreign investment. Last January, Prime Minister Modi and President Obama issued a joint statement which &ldquo;committed to establish an annual high-level Intellectual Property Working Group&rdquo;. In November, Modi said in Singapore that &ldquo;India is committed to protect the intellectual property rights of all innovators&rdquo;. And now, the Cabinet is expected to discuss a &lsquo;new IPR policy&rsquo; in a month.<br />
<br />
It appears that MNCs have lobbied with world governments after two setbacks in 2013. In April that year, the Supreme Court struck down a patent for Novartis&rsquo; leukemia drug, Glivec, citing Section 3 (d) of the Patents Act which disallows superficial innovation. In March 2013, the Intellectual Property Appellate Board awarded Natco Pharma a compulsory licence to make and sell a cheaper version of Bayer&rsquo;s anti-cancer drug, Nexavar. The MNCs&rsquo; gripe against India&rsquo;s patent law is unjustified. In the book, Politics Trumps Economics, Sunil Mani points out that the share of foreign companies in business enterprise R&amp;D expenditure increased from 10 per cent in 2003 to 29 per cent in 2011. What&rsquo;s more, &ldquo;with tighter TRIPS-compliant IPR regime put in place by India, from 2005 onwards, the possibility of spill-overs to the domestic economy from the R&amp;D done by these foreign companies stands greatly diminished&rdquo;, he says. In other words, the MNCs are doing pretty well for themselves.<br />
<br />
Our patent law merely deploys the safeguards allowed in TRIPS to protect domestic consumers and industry. It is considered a model for the developing world. It enabled India to supply cheap anti-HIV drugs to South Africa. Why dismantle this system? India arguably conceded enough at the Nairobi ministerial. Our IPRs laws should be non-negotiable.
</div>',
		'credit_writer' => 'The Hindu Business Line, 8 January, 2016, http://www.thehindubusinessline.com/opinion/columns/dont-tamper-with-patent-laws/article8082555.ece?homepage=true',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'dont-tamper-with-patent-laws-a-srinivas-4678290',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 4678290,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 30230,
	'metaTitle' => 'LATEST NEWS UPDATES | Don’t tamper with patent laws -A Srinivas',
	'metaKeywords' => 'Intellectual Property Rights,IPRs,patent,Patented Medicines,patents,FDI,Foreign Direct Investment',
	'metaDesc' => '
-The Hindu Business Line

India is being too accommodating of MNCs

The Centre is needlessly apologetic about our IPR laws. It set up an IPR &lsquo;think tank&rsquo; in October 2014, perhaps responding to a view that our IPRs are not strong enough...',
	'disp' => '<div align="justify">-The Hindu Business Line<br /><br /><em>India is being too accommodating of MNCs<br /></em><br />The Centre is needlessly apologetic about our IPR laws. It set up an IPR &lsquo;think tank&rsquo; in October 2014, perhaps responding to a view that our IPRs are not strong enough to invite foreign investment. Last January, Prime Minister Modi and President Obama issued a joint statement which &ldquo;committed to establish an annual high-level Intellectual Property Working Group&rdquo;. In November, Modi said in Singapore that &ldquo;India is committed to protect the intellectual property rights of all innovators&rdquo;. And now, the Cabinet is expected to discuss a &lsquo;new IPR policy&rsquo; in a month.<br /><br />It appears that MNCs have lobbied with world governments after two setbacks in 2013. In April that year, the Supreme Court struck down a patent for Novartis&rsquo; leukemia drug, Glivec, citing Section 3 (d) of the Patents Act which disallows superficial innovation. In March 2013, the Intellectual Property Appellate Board awarded Natco Pharma a compulsory licence to make and sell a cheaper version of Bayer&rsquo;s anti-cancer drug, Nexavar. The MNCs&rsquo; gripe against India&rsquo;s patent law is unjustified. In the book, Politics Trumps Economics, Sunil Mani points out that the share of foreign companies in business enterprise R&amp;D expenditure increased from 10 per cent in 2003 to 29 per cent in 2011. What&rsquo;s more, &ldquo;with tighter TRIPS-compliant IPR regime put in place by India, from 2005 onwards, the possibility of spill-overs to the domestic economy from the R&amp;D done by these foreign companies stands greatly diminished&rdquo;, he says. In other words, the MNCs are doing pretty well for themselves.<br /><br />Our patent law merely deploys the safeguards allowed in TRIPS to protect domestic consumers and industry. It is considered a model for the developing world. It enabled India to supply cheap anti-HIV drugs to South Africa. Why dismantle this system? India arguably conceded enough at the Nairobi ministerial. Our IPRs laws should be non-negotiable.</div>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 30230,
	'title' => 'Don’t tamper with patent laws -A Srinivas',
	'subheading' => '',
	'description' => '<div align="justify">
-The Hindu Business Line<br />
<br />
<em>India is being too accommodating of MNCs<br />
</em><br />
The Centre is needlessly apologetic about our IPR laws. It set up an IPR &lsquo;think tank&rsquo; in October 2014, perhaps responding to a view that our IPRs are not strong enough to invite foreign investment. Last January, Prime Minister Modi and President Obama issued a joint statement which &ldquo;committed to establish an annual high-level Intellectual Property Working Group&rdquo;. In November, Modi said in Singapore that &ldquo;India is committed to protect the intellectual property rights of all innovators&rdquo;. And now, the Cabinet is expected to discuss a &lsquo;new IPR policy&rsquo; in a month.<br />
<br />
It appears that MNCs have lobbied with world governments after two setbacks in 2013. In April that year, the Supreme Court struck down a patent for Novartis&rsquo; leukemia drug, Glivec, citing Section 3 (d) of the Patents Act which disallows superficial innovation. In March 2013, the Intellectual Property Appellate Board awarded Natco Pharma a compulsory licence to make and sell a cheaper version of Bayer&rsquo;s anti-cancer drug, Nexavar. The MNCs&rsquo; gripe against India&rsquo;s patent law is unjustified. In the book, Politics Trumps Economics, Sunil Mani points out that the share of foreign companies in business enterprise R&amp;D expenditure increased from 10 per cent in 2003 to 29 per cent in 2011. What&rsquo;s more, &ldquo;with tighter TRIPS-compliant IPR regime put in place by India, from 2005 onwards, the possibility of spill-overs to the domestic economy from the R&amp;D done by these foreign companies stands greatly diminished&rdquo;, he says. In other words, the MNCs are doing pretty well for themselves.<br />
<br />
Our patent law merely deploys the safeguards allowed in TRIPS to protect domestic consumers and industry. It is considered a model for the developing world. It enabled India to supply cheap anti-HIV drugs to South Africa. Why dismantle this system? India arguably conceded enough at the Nairobi ministerial. Our IPRs laws should be non-negotiable.
</div>',
	'credit_writer' => 'The Hindu Business Line, 8 January, 2016, http://www.thehindubusinessline.com/opinion/columns/dont-tamper-with-patent-laws/article8082555.ece?homepage=true',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'dont-tamper-with-patent-laws-a-srinivas-4678290',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 4678290,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {},
		(int) 2 => object(Cake\ORM\Entity) {},
		(int) 3 => object(Cake\ORM\Entity) {},
		(int) 4 => object(Cake\ORM\Entity) {},
		(int) 5 => object(Cake\ORM\Entity) {},
		(int) 6 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 30230
$metaTitle = 'LATEST NEWS UPDATES | Don’t tamper with patent laws -A Srinivas'
$metaKeywords = 'Intellectual Property Rights,IPRs,patent,Patented Medicines,patents,FDI,Foreign Direct Investment'
$metaDesc = '
-The Hindu Business Line

India is being too accommodating of MNCs

The Centre is needlessly apologetic about our IPR laws. It set up an IPR &lsquo;think tank&rsquo; in October 2014, perhaps responding to a view that our IPRs are not strong enough...'
$disp = '<div align="justify">-The Hindu Business Line<br /><br /><em>India is being too accommodating of MNCs<br /></em><br />The Centre is needlessly apologetic about our IPR laws. It set up an IPR &lsquo;think tank&rsquo; in October 2014, perhaps responding to a view that our IPRs are not strong enough to invite foreign investment. Last January, Prime Minister Modi and President Obama issued a joint statement which &ldquo;committed to establish an annual high-level Intellectual Property Working Group&rdquo;. In November, Modi said in Singapore that &ldquo;India is committed to protect the intellectual property rights of all innovators&rdquo;. And now, the Cabinet is expected to discuss a &lsquo;new IPR policy&rsquo; in a month.<br /><br />It appears that MNCs have lobbied with world governments after two setbacks in 2013. In April that year, the Supreme Court struck down a patent for Novartis&rsquo; leukemia drug, Glivec, citing Section 3 (d) of the Patents Act which disallows superficial innovation. In March 2013, the Intellectual Property Appellate Board awarded Natco Pharma a compulsory licence to make and sell a cheaper version of Bayer&rsquo;s anti-cancer drug, Nexavar. The MNCs&rsquo; gripe against India&rsquo;s patent law is unjustified. In the book, Politics Trumps Economics, Sunil Mani points out that the share of foreign companies in business enterprise R&amp;D expenditure increased from 10 per cent in 2003 to 29 per cent in 2011. What&rsquo;s more, &ldquo;with tighter TRIPS-compliant IPR regime put in place by India, from 2005 onwards, the possibility of spill-overs to the domestic economy from the R&amp;D done by these foreign companies stands greatly diminished&rdquo;, he says. In other words, the MNCs are doing pretty well for themselves.<br /><br />Our patent law merely deploys the safeguards allowed in TRIPS to protect domestic consumers and industry. It is considered a model for the developing world. It enabled India to supply cheap anti-HIV drugs to South Africa. Why dismantle this system? India arguably conceded enough at the Nairobi ministerial. Our IPRs laws should be non-negotiable.</div>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

Don’t tamper with patent laws -A Srinivas

-The Hindu Business Line India is being too accommodating of MNCs The Centre is needlessly apologetic about our IPR laws. It set up an IPR ‘think tank’ in October 2014, perhaps responding to a view that our IPRs are not strong enough to invite foreign investment. Last January, Prime Minister Modi and President Obama issued a joint statement which “committed to establish an annual high-level Intellectual Property Working Group”. In November, Modi said in Singapore that “India is committed to protect the intellectual property rights of all innovators”. And now, the Cabinet is expected to discuss a ‘new IPR policy’ in a month. It appears that MNCs have lobbied with world governments after two setbacks in 2013. In April that year, the Supreme Court struck down a patent for Novartis’ leukemia drug, Glivec, citing Section 3 (d) of the Patents Act which disallows superficial innovation. In March 2013, the Intellectual Property Appellate Board awarded Natco Pharma a compulsory licence to make and sell a cheaper version of Bayer’s anti-cancer drug, Nexavar. The MNCs’ gripe against India’s patent law is unjustified. In the book, Politics Trumps Economics, Sunil Mani points out that the share of foreign companies in business enterprise R&D expenditure increased from 10 per cent in 2003 to 29 per cent in 2011. What’s more, “with tighter TRIPS-compliant IPR regime put in place by India, from 2005 onwards, the possibility of spill-overs to the domestic economy from the R&D done by these foreign companies stands greatly diminished”, he says. In other words, the MNCs are doing pretty well for themselves. Our patent law merely deploys the safeguards allowed in TRIPS to protect domestic consumers and industry. It is considered a model for the developing world. It enabled India to supply cheap anti-HIV drugs to South Africa. Why dismantle this system? India arguably conceded enough at the Nairobi ministerial. Our IPRs laws should be non-negotiable.